{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:00:25Z","timestamp":1790319625896,"version":"4.1.0"},"reference-count":72,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T00:00:00Z","timestamp":1567728000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R37NS041435"],"award-info":[{"award-number":["R37NS041435"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS050274"],"award-info":[{"award-number":["NS050274"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004628","name":"Medimmune","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004628","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0221747","type":"journal-article","created":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T17:33:42Z","timestamp":1567791222000},"page":"e0221747","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Quetiapine has an additive effect to triiodothyronine in inducing differentiation of oligodendrocyte precursor cells through induction of cholesterol biosynthesis"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7539-1734","authenticated-orcid":true,"given":"Jaime","family":"Gonzalez Cardona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6614-569X","authenticated-orcid":true,"given":"Matthew D.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason T.","family":"Schott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodi L.","family":"Karnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine A.","family":"Whartenby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Calabresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,9,6]]},"reference":[{"key":"pone.0221747.ref001","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1056\/NEJMoa010994","article-title":"Premyelinating Oligodendrocytes in Chronic Lesions of Multiple Sclerosis","volume":"346","author":"A Chang","year":"2002","journal-title":"N Engl J Med"},{"key":"pone.0221747.ref002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a028936","article-title":"Multiple sclerosis pathology","volume":"8","author":"H Lassmann","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"pone.0221747.ref003","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple Sclerosis","volume":"378","author":"DS Reich","year":"2018","journal-title":"N Engl J Med"},{"key":"pone.0221747.ref004","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1750-3639.2007.00064.x","article-title":"The Immunopathology of Multiple Sclerosis: An Overview","volume":"17","author":"H Lassmann","year":"2007","journal-title":"Brain Pathol"},{"key":"pone.0221747.ref005","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrneurol.2012.168","article-title":"Progressive multiple sclerosis: Pathology and pathogenesis","volume":"8","author":"H Lassmann","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"pone.0221747.ref006","first-page":"1","article-title":"Glia disease and repair\u2014Remyelination","volume":"7","author":"RJM Franklin","year":"2015","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"pone.0221747.ref007","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nrn.2017.136","article-title":"Regenerating CNS myelin\u2014From mechanisms to experimental medicines","volume":"18","author":"RJM Franklin","year":"2017","journal-title":"Nat Rev Neurosci"},{"key":"pone.0221747.ref008","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.neuron.2013.01.006","article-title":"Oligodendrocyte dynamics in the healthy adult CNS: Evidence for myelin remodeling","volume":"77","author":"KM Young","year":"2013","journal-title":"Neuron"},{"key":"pone.0221747.ref009","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/nn.2220","article-title":"PDGFRA\/NG2 glia generate myelinating oligodendrocytes and piriform projection neurons in adult mice","volume":"11","author":"LE Rivers","year":"2008","journal-title":"Nat Neurosci"},{"key":"pone.0221747.ref010","doi-asserted-by":"crossref","first-page":"6404","DOI":"10.1523\/JNEUROSCI.20-17-06404.2000","article-title":"NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions","volume":"20","author":"a Chang","year":"2000","journal-title":"J Neurosci"},{"key":"pone.0221747.ref011","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.neuron.2010.09.009","article-title":"NG2+ CNS glial progenitors remain committed to the oligodendrocyte lineage in postnatal life and following neurodegeneration","volume":"68","author":"SH Kang","year":"2010","journal-title":"Neuron"},{"key":"pone.0221747.ref012","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S1044-7431(03)00210-0","article-title":"NG2-expressing glial progenitor cells: An abundant and widespread population of cycling cells in the adult rat CNS","volume":"24","author":"MRL Dawson","year":"2003","journal-title":"Mol Cell Neurosci"},{"key":"pone.0221747.ref013","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jneuroim.2006.04.014","article-title":"Co-expression of PDGF \u03b1 receptor and NG2 by oligodendrocyte precursors in human CNS and multiple sclerosis lesions","volume":"176","author":"HC Wilson","year":"2006","journal-title":"J Neuroimmunol"},{"key":"pone.0221747.ref014","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1469-7580.2005.00454.x","article-title":"NG2-expressing cells as oligodendrocyte progenitors in the normal and demyelinated adult central nervous system","volume":"207","author":"A Polito","year":"2005","journal-title":"J Anat"},{"key":"pone.0221747.ref015","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrneurol.2010.37","article-title":"Signals to promote myelin formation and repair","volume":"6","author":"C Taveggia","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"pone.0221747.ref016","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuroscience.2013.11.029","article-title":"Mechanisms regulating the development of oligodendrocytes and central nervous system myelin","volume":"276","author":"S Mitew","year":"2014","journal-title":"Neuroscience"},{"key":"pone.0221747.ref017","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.mcn.2012.03.007","article-title":"The T3-induced gene KLF9 regulates oligodendrocyte differentiation and myelin regeneration","volume":"50","author":"JC Dugas","year":"2012","journal-title":"Mol Cell Neurosci"},{"key":"pone.0221747.ref018","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.expneurol.2008.04.039","article-title":"Thyroid hormones promote differentiation of oligodendrocyte progenitor cells and improve remyelination after cuprizone-induced demyelination","volume":"212","author":"PG Franco","year":"2008","journal-title":"Exp Neurol"},{"key":"pone.0221747.ref019","doi-asserted-by":"crossref","first-page":"1097 LP","DOI":"10.1242\/dev.120.5.1097","article-title":"A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development","volume":"120","author":"BA Barres","year":"1994","journal-title":"Development"},{"key":"pone.0221747.ref020","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/nn1426","article-title":"High cholesterol level is essential for myelin membrane growth","volume":"8","author":"G Saher","year":"2005","journal-title":"Nat Neurosci"},{"key":"pone.0221747.ref021","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1002\/jnr.22490","article-title":"Simvastatin interferes with process outgrowth and branching of oligodendrocytes","volume":"88","author":"I Smolders","year":"2010","journal-title":"J Neurosci Res"},{"key":"pone.0221747.ref022","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/glia.20441","article-title":"Simvastatin regulates oligodendroglial process dynamics and survival","volume":"55","author":"VE Miron","year":"2007","journal-title":"Glia"},{"key":"pone.0221747.ref023","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.2353\/ajpath.2009.080947","article-title":"Statin therapy inhibits remyelination in the central nervous system","volume":"174","author":"VE Miron","year":"2009","journal-title":"Am J Pathol"},{"key":"pone.0221747.ref024","doi-asserted-by":"crossref","first-page":"13609","DOI":"10.1523\/JNEUROSCI.2765-08.2008","article-title":"Negative Impact of Statins on Oligodendrocytes and Myelin Formation In Vitro and In Vivo","volume":"28","author":"S Klopfleisch","year":"2008","journal-title":"J Neurosci"},{"key":"pone.0221747.ref025","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature14335","article-title":"Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo","volume":"522","author":"FJ Najm","year":"2015","journal-title":"Nature"},{"key":"pone.0221747.ref026","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature12647","article-title":"A regenerative approach to the treatment of multiple sclerosis","volume":"502","author":"VA Deshmukh","year":"2013","journal-title":"Nature"},{"key":"pone.0221747.ref027","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s41586-018-0360-3","article-title":"Accumulation of 8,9-unsaturated sterols drives oligodendrocyte formation and remyelination","volume":"560","author":"Z Hubler","year":"2018","journal-title":"Nature"},{"key":"pone.0221747.ref028","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/sj.mp.4002064","article-title":"Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes","volume":"13","author":"L Xiao","year":"2008","journal-title":"Mol Psychiatry"},{"key":"pone.0221747.ref029","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1111\/j.1742-4658.2008.06519.x","article-title":"Demonstration of an anti-oxidative stress mechanism of quetiapine","volume":"275","author":"H Xu","year":"2008","journal-title":"FEBS J"},{"key":"pone.0221747.ref030","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/nm.3618","article-title":"Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis","volume":"20","author":"F Mei","year":"2014","journal-title":"Nat Med"},{"key":"pone.0221747.ref031","doi-asserted-by":"crossref","first-page":"e42746","DOI":"10.1371\/journal.pone.0042746","article-title":"Quetiapine, an Atypical Antipsychotic, Is Protective against Autoimmune-Mediated Demyelination by Inhibiting Effector T Cell Proliferation","volume":"7","author":"F Mei","year":"2012","journal-title":"PLoS One"},{"key":"pone.0221747.ref032","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.schres.2008.09.013","article-title":"Quetiapine alleviates the cuprizone-induced white matter pathology in the brain of C57BL\/6 mouse","volume":"106","author":"Y Zhang","year":"2008","journal-title":"Schizophr Res"},{"key":"pone.0221747.ref033","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.schres.2012.04.006","article-title":"Quetiapine enhances oligodendrocyte regeneration and myelin repair after cuprizone-induced demyelination","volume":"138","author":"Y Zhang","year":"2012","journal-title":"Schizophr Res"},{"key":"pone.0221747.ref034","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ejphar.2015.08.046","article-title":"Quetiapine mitigates the neuroinflammation and oligodendrocyte loss in the brain of C57BL\/6 mouse following cuprizone exposure for one week","volume":"765","author":"Y Shao","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"pone.0221747.ref035","first-page":"53764","article-title":"Preparation of Rat Oligodendrocyte Progenitor Cultures and Quantification of Oligodendrogenesis Using Dual-infrared Fluorescence Scanning","author":"JT Schott","year":"2016","journal-title":"J Vis Exp"},{"key":"pone.0221747.ref036","first-page":"514","article-title":"Growth of a rat neuroblastoma cell line in serum-free supplemented medium (growth regulation\/B104 cells\/neurite extension\/central nervous system)","volume":"76","author":"JE Bottenstein","year":"1979","journal-title":"Neurobiology"},{"key":"pone.0221747.ref037","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"A Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0221747.ref038","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database Hallmark Gene Set Collection","volume":"1","author":"A Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"pone.0221747.ref039","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cmet.2010.12.004","article-title":"Inhibition of SREBP by a Small Molecule, Betulin, Improves Hyperlipidemia and Insulin Resistance and Reduces Atherosclerotic Plaques","volume":"13","author":"J-J Tang","year":"2011","journal-title":"Cell Metab"},{"key":"pone.0221747.ref040","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nri1839","article-title":"Statin therapy and autoimmune disease: From protein prenylation to immunomodulation","volume":"6","author":"J Greenwood","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"pone.0221747.ref041","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.3892\/or.2015.4045","article-title":"Induction of apoptotic cell death by betulin in multidrug-resistant human renal carcinoma cells","volume":"34","author":"N-H Yim","year":"2015","journal-title":"Oncol Rep"},{"key":"pone.0221747.ref042","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1177\/1535370214565975","article-title":"Thyroid hormone alleviates demyelination induced by cuprizone through its role in remyelination during the remission period","volume":"240","author":"M Zhang","year":"2015","journal-title":"Exp Biol Med (Maywood)"},{"key":"pone.0221747.ref043","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/glia.22697","article-title":"A selective thyroid hormone \u03b2 receptor agonist enhances human and rodent oligodendrocyte differentiation","volume":"62","author":"EG Baxi","year":"2014","journal-title":"Glia"},{"key":"pone.0221747.ref044","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.pnpbp.2007.06.031","article-title":"The effect of atypical antipsychotics, perospirone, ziprasidone and quetiapine on microglial activation induced by interferon-\u03b3","volume":"32","author":"Q Bian","year":"2008","journal-title":"Prog Neuro-Psychopharmacology Biol Psychiatry"},{"key":"pone.0221747.ref045","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3389\/fncel.2015.00492","article-title":"Quetiapine Inhibits Microglial Activation by Neutralizing Abnormal STIM1-Mediated Intercellular Calcium Homeostasis and Promotes Myelin Repair in a Cuprizone-Induced Mouse Model of Demyelination","volume":"9","author":"H Wang","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"pone.0221747.ref046","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/cns.12154","article-title":"Quetiapine fumarate for the treatment of multiple sclerosis: Focus on myelin repair","volume":"19","author":"S Zhornitsky","year":"2013","journal-title":"CNS Neurosci Ther"},{"key":"pone.0221747.ref047","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/tpj.2009.62","article-title":"Antipsychotic drugs upregulate lipogenic gene expression by disrupting intracellular trafficking of lipoprotein-derived cholesterol","volume":"10","author":"I Kristiana","year":"2010","journal-title":"Pharmacogenomics J"},{"key":"pone.0221747.ref048","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1471-2202-7-69","article-title":"Drug-induced activation of SREBP-controlled lipogenic gene expression in CNS-related cell lines: marked differences between various antipsychotic drugs","volume":"7","author":"J Fern\u00f8","year":"2006","journal-title":"BMC Neurosci"},{"key":"pone.0221747.ref049","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cell.2005.12.022","article-title":"Protein sensors for membrane sterols","volume":"124","author":"JL Goldstein","year":"2006","journal-title":"Cell"},{"key":"pone.0221747.ref050","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nature01158","article-title":"The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease","volume":"420","author":"S Youssef","year":"2002","journal-title":"Nature"},{"key":"pone.0221747.ref051","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1212\/WNL.59.7.990","article-title":"Statins as immunomodulators: Comparison with interferon- 1b in MS","volume":"59","author":"O Neuhaus","year":"2002","journal-title":"Neurology"},{"key":"pone.0221747.ref052","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(04)16205-3","article-title":"Oral simvastatin treatment in relapsing-remitting multiple sclerosis","volume":"363","author":"T Vollmer","year":"2004","journal-title":"Lancet"},{"key":"pone.0221747.ref053","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1084\/jem.20051129","article-title":"Isoprenoids determine Th1\/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin","volume":"203","author":"SE Dunn","year":"2006","journal-title":"J Exp Med"},{"key":"pone.0221747.ref054","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.clineuro.2008.03.021","article-title":"Central nervous system effects of current and emerging multiple sclerosis-directed immuno-therapies","volume":"110","author":"JP Antel","year":"2008","journal-title":"Clin Neurol Neurosurg"},{"key":"pone.0221747.ref055","doi-asserted-by":"crossref","first-page":"e1928","DOI":"10.1371\/journal.pone.0001928","article-title":"Oral High-Dose Atorvastatin Treatment in Relapsing-Remitting Multiple Sclerosis","volume":"3","author":"F Paul","year":"2008","journal-title":"PLoS One"},{"key":"pone.0221747.ref056","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1177\/1352458510369147","article-title":"Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial","volume":"16","author":"M Togha","year":"2010","journal-title":"Mult Scler J"},{"key":"pone.0221747.ref057","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1212\/WNL.0b013e31824f7fdd","article-title":"Randomized controlled trial of atorvastatin in clinically isolated syndrome","volume":"78","author":"E Waubant","year":"2012","journal-title":"Neurology"},{"key":"pone.0221747.ref058","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1124\/mol.107.044230","article-title":"Inhibition of rho family functions by lovastatin promotes myelin repair in ameliorating experimental autoimmune encephalomyelitis","volume":"73","author":"AS Paintlia","year":"2008","journal-title":"Mol Pharmacol"},{"key":"pone.0221747.ref059","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/glia.20441","article-title":"Simvastatin regulates oligodendroglial process dynamics and survival","volume":"55","author":"VE Miron","year":"2007","journal-title":"Glia"},{"key":"pone.0221747.ref060","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ana.21972","article-title":"Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis","volume":"67","author":"EM Mowry","year":"2010","journal-title":"Ann Neurol"},{"key":"pone.0221747.ref061","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/ana.23591","article-title":"Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis","volume":"72","author":"EM Mowry","year":"2012","journal-title":"Ann Neurol"},{"key":"pone.0221747.ref062","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.22043","article-title":"Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis","volume":"68","author":"S Simpson","year":"2010","journal-title":"Ann Neurol"},{"key":"pone.0221747.ref063","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1177\/1352458509102844","article-title":"Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis","volume":"15","author":"GS Hiremath","year":"2009","journal-title":"Mult Scler"},{"key":"pone.0221747.ref064","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1177\/1352458508094399","article-title":"Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis","volume":"14","author":"J Smolders","year":"2008","journal-title":"Mult Scler"},{"key":"pone.0221747.ref065","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/brain\/120.6.1067","article-title":"The neuroendocrine axis in patients with multiple sclerosis","volume":"120","author":"T Wei","year":"1997","journal-title":"Brain"},{"key":"pone.0221747.ref066","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0165-5728(03)00177-2","article-title":"Dysregulation of the hypothalamic-pituitary-gonadal axis in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"140","author":"SC Foster","year":"2003","journal-title":"J Neuroimmunol"},{"key":"pone.0221747.ref067","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ana.24250","article-title":"Testicular hypofunction and multiple sclerosis risk: A record-linkage study","volume":"76","author":"J Pakpoor","year":"2014","journal-title":"Ann Neurol"},{"key":"pone.0221747.ref068","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1177\/1352458514527864","article-title":"Low testosterone is associated with disability in men with multiple sclerosis","volume":"20","author":"R Bove","year":"2014","journal-title":"Mult Scler J"},{"key":"pone.0221747.ref069","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1001\/jama.296.23.2832","article-title":"Serum 25-Hydroxyvitamin D Levels and Risk of Multiple Sclerosis","volume":"296","author":"KL Munger","year":"2006","journal-title":"JAMA"},{"key":"pone.0221747.ref070","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/S0140-6736(13)62242-4","article-title":"Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial","volume":"383","author":"J Chataway","year":"2014","journal-title":"Lancet"},{"key":"pone.0221747.ref071","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.lfs.2013.08.004","article-title":"Antipsychotics promote the differentiation of oligodendrocyte progenitor cells by regulating oligodendrocyte lineage transcription factors 1 and 2","volume":"93","author":"F Fang","year":"2013","journal-title":"Life Sci"},{"key":"pone.0221747.ref072","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.1038\/tp.2013.19","article-title":"Unique pharmacological actions of atypical neuroleptic quetiapine: possible role in cell cycle\/fate control","volume":"3","author":"MA Kondo","year":"2013","journal-title":"Transl Psychiatry"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0221747","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T02:09:55Z","timestamp":1721700595000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0221747"}},"subtitle":[],"editor":[{"given":"Fernando","family":"de Castro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,9,6]]},"references-count":72,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,9,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0221747","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,6]]}}}